Neuronetics, Inc. · NASDAQ:STIM
Madryn Asset Management, LP reported a 21.60% stake in Neuronetics, Inc. (Schedule 13D/A)
Event Nov 12, 2026 · Filed Nov 16, 2026
Madryn Asset Management, LP reported a 21.60% stake in Neuronetics, Inc., 20,809,561 shares, with active intent on Nov 12, 2026. Filed Nov 16, 2026 (Schedule 13D/A).
- Stake
- 21.60%
- Shares
- 20,809,561
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 8 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| MADRYN ASSET MANAGEMENT, LP | 21.60% | 20,809,561 |
| MADRYN HEALTH PARTNERS II, LP | 1.50% | 1,435,958 |
| MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP | 17.70% | 17,104,530 |
| MADRYN HEALTH ADVISORS II, LP | 19.20% | 18,540,488 |
| MADRYN HEALTH ADVISORS GP II, LLC | 19.20% | 18,540,488 |
| MADRYN SELECT OPPORTUNITIES, LP | 2.40% | 2,269,073 |
| MADRYN SELECT ADVISORS, LP | 2.40% | 2,269,073 |
| MADRYN SELECT ADVISORS GP, LLC | 2.40% | 2,269,073 |
Source
Download original · View original at SEC
Related
- Neuronetics, Inc.
- Madryn Asset Management, LP
- Neuronetics, Inc. shareholders
- Schedule 13D/A · Madryn Asset Management, LP · Mar 4, 2026
- Schedule 13D/A · Madryn Asset Management, LP · Aug 12, 2025
- Form 4/A · Muir Glenn P · Nov 19, 2026
- Form 4 · Muir Glenn P · Nov 18, 2026
- Form 4 · Cucuz Sasha · Nov 16, 2026
- Form 4 · Cascella Robert · Nov 16, 2026
- Schedule 13D/A · Chernett Jorey · Nov 16, 2026